Continuing Education
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DIA. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.75 contact hours.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 2.75 contact hours.
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. This program is designated for up to 2.75 contact hours or .275 continuing education units (CEUs). Type of Activity: Knowledge 0286-0000-26-504-L04-P
Drug Information Association (DIA) is accredited by the International Accreditors for Continuing Education and Training (IACET) and offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. IACET is recognized internationally as a standard development organization and accrediting body that promotes quality of Continuing Education and Training.
As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .3 CEUs for this program.
Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
| Name | Credit Type | Max Credits | CEU |
| Aggregate Safety Assessment Planning Process | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Aggregate Safety Assessment Planning Process | Credit TypeCME | Max Credits2.75 | CEU0.000 |
| Aggregate Safety Assessment Planning Process | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| Aggregate Safety Assessment Planning Process | Credit TypeRN | Max Credits2.75 | CEU0.000 |
| AI Applications, Ethics, Regulations, and Governance for Life Sciences | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| AI Applications, Ethics, Regulations, and Governance for Life Sciences | Credit TypeCME | Max Credits2.75 | CEU0.000 |
| AI Applications, Ethics, Regulations, and Governance for Life Sciences | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| AI Applications, Ethics, Regulations, and Governance for Life Sciences | Credit TypeRN | Max Credits2.75 | CEU0.000 |
| Cell and Gene Therapies 101: Specific Regulatory, CMC, Non-Clinical, and Clinical Requirements and Considerations | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Cell and Gene Therapies 101: Specific Regulatory, CMC, Non-Clinical, and Clinical Requirements and Considerations | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| Extractables and Leachables Harmonization: Risk-Based Approaches for Complex Generic Development | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Extractables and Leachables Harmonization: Risk-Based Approaches for Complex Generic Development | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| From Quality by Design via Critical to Quality Factors to Risk Based Quality Management: How Does it Tie Together? | Credit TypeACPE | Max Credits6.75 | CEU0.675 |
| Navigating Gen AI Revolution in Pharma: From Unlocking Data Insight to Practical Application | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Navigating Gen AI Revolution in Pharma: From Unlocking Data Insight to Practical Application | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| Real-World Evidence for Regulatory Decision-Making: Guidance, Methods, and Case Studies | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Real-World Evidence for Regulatory Decision-Making: Guidance, Methods, and Case Studies | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| Regulatory Strategy Development for Complex Devices and Combination Products | Credit TypeACPE | Max Credits2.75 | CEU0.275 |
| Regulatory Strategy Development for Complex Devices and Combination Products | Credit TypeCME | Max Credits2.75 | CEU0.000 |
| Regulatory Strategy Development for Complex Devices and Combination Products | Credit TypeIACET | Max Credits2.75 | CEU0.300 |
| Regulatory Strategy Development for Complex Devices and Combination Products | Credit TypeRN | Max Credits2.75 | CEU0.000 |
| Root Cause Analysis and CAPA Management: Your Essential Toolkit for Best Practices | Credit TypeACPE | Max Credits6.50 | CEU0.650 |
Statement of Credit:
If you would like to receive a statement of credit, you must attend the live virtual short course, complete the pre-assessment, achieve a passing score of 80% or better on the post-assessment, and complete the evaluation in the DIA Learning Center after the event. My Transcript will be available for credit request on Wednesday, June 10, 2026.
Sign in to My Account to access My Transcripts and request your online credit.
To review DIA’s Disclosure and Grievance Policy, visit DIAglobal.org/CE
Have an account?